Balance Sheet

Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Evolv Technologies Holdings (EVLV) Other financing activities (2020 - 2021)

Evolv Technologies Holdings (EVLV) has disclosed Other financing activities for 2 consecutive years, with $164000.0 as the latest value for Q4 2021.

Quarterly Other financing activities rose 4000.0% to $164000.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $612000.0 through Dec 2022, up 8.9% year-over-year, with the annual reading at $34.1 million for FY2021, 6753.82% up from the prior year.
Other financing activities hit $164000.0 in Q4 2021 for Evolv Technologies Holdings, up from $4000.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $444000.0 in Q3 2020 to a low of -$50000.0 in Q2 2020.